Late conversion to mycophenolate mofetil for chronic deterioration of renal allograft function.
Fritsche
L
L
Department of Nephrology and Transplantation, Charité, Berlin, Germany.
Sperschneider
H
H
Budde
K
K
Giessing
M
M
Türk
H
H
Böhler
T
T
Schröder
K
K
Stein
G
G
Neumayer
H H
HH
D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D019992:Databases as Topic; D005260:Female; D005919:Glomerular Filtration Rate / Q000187:drug effects*; D006084:Graft Rejection / Q000188:drug therapy* / Q000473:pathology / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008297:Male; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D016559:Tacrolimus / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011239:Prednisolone; D009173:Mycophenolic Acid; D001379:Azathioprine; D016559:Tacrolimus